Hemodynamic Effects of Partial Correction of Chronic Anemia by Recombinant Human Erythropoietin in Patients on Dialysis
- 1 March 1991
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 17 (3) , 286-289
- https://doi.org/10.1016/s0272-6386(12)80475-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Quality of Life of Hemodialysis Recipients Treated With Recombinant Human ErythropoietinJAMA, 1990
- Anaemia and reduced exercise capacity in patients on chronic haemodialysisClinical Science, 1989
- Rheology in Whole Blood and in Red Blood Cells under Recombinant Human Erythropoietin TherapyPublished by S. Karger AG ,1988
- USA Multicenter Clinical Trial with Recombinant Human Erythropoietin (Amgen)Published by S. Karger AG ,1988
- Peripheral Hemodynamics, Blood Viscosity, and the Renin-Angiotensin System in Hemodialysis Patients under Therapy with Recombinant Human ErythropoietinPublished by S. Karger AG ,1988
- Working capacity is increased following recombinant human erythropoietin treatmentKidney International, 1988
- Blood Rheology and Hypertension in Hemodialysis Patients Treated with ErythropoietinAmerican Journal of Nephrology, 1988
- Blood Pressure Changes during Treatment with Recombinant Human ErythropoietinPublished by S. Karger AG ,1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986